Nivolumab Maintenance as Monotherapy after Carboplatin Plus Nab- Paclitaxel for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Study Protocol for Feasibility

Journal Title: UNKNOWN - Year 2017, Vol 7, Issue 5

Abstract

The aim of this study is to determine the feasibility of nivolumab as maintenance therapy after first-line chemotherapy with carboplatin plus nab-paclitaxel in non-small-cell lung cancer. Since we cannot change the dose of nivolumab, we will investigate the recommended doses and cycles of pretreatment chemotherapy with carboplatin plus nab-paclitaxel that affect maintenance therapy. The primary endpoint is incidence of any grade ≥ 3 adverse events during the first 12 weeks of nivolumab treatment. Twelve patients are required in this study

Authors and Affiliations

Masao Ichiki, Ken Masuda, Chiyo Yano, Yusuke Okayama, Hanako Oda, Yohei Imamura, Hiroaki Takeoka, Tomoaki Hoshino

Keywords

Related Articles

Safety and Efficacy of Intracoronary Ad-HGF Administration for Treating Severe Coronary Disease: Results From Long-Term Follow-Up of a Phase I Clinical Trial

Objective: This study is a long-term follow-up of our previous phase I clinical trial and aims at evaluating the long-term safety and efficacy of intracoronary Ad-HGF administration for treating coronary disease. Method...

Myocardial Ischemia and Infarction Related to the Highly Sensitive Cardiac Troponin after Noncardiac Surgery: A Review

Although Acute Myocardial Infarct (AMI) from its classic symptomatology added or not to electrocardiographic changes is a significant cause of perioperative associated mortality, when it is only plotted from the enzymati...

Keratosis Lesion on the Nose

Porokeratosis (PK) is a rare skin disease, of unknown etiology, probably due to a disorder of epidermal keratinization. We describe a 24 year-old male patient, with porokeratosis of Mibelli confirmed histopathologically....

Cutaneous Necrosis after Peripheral Venous Perfusion of Adrenaline

A 30 year old female patient was hospitalized for septic shock owing to peritonitis due to perforated viscus. The patient’s hemodynamic status was labile and a peripheral venous access line was established for the perfus...

Toward a Comprehensive and Accurate Measure of Clinical Trial Workload, Equity, Quality Assurance and Patient Safety-How Much Workload is Too Much? Commentary and Brief Research Report

This article provides a brief commentary on the methodology surrounding controlled clinical trials, the growing trend of centers conducting multiple controlled trials (i.e. “factory science”), trial workload measures, an...

Download PDF file
  • EP ID EP387005
  • DOI 10.4172/2167-0870.1000325
  • Views 70
  • Downloads 0

How To Cite

Masao Ichiki, Ken Masuda, Chiyo Yano, Yusuke Okayama, Hanako Oda, Yohei Imamura, Hiroaki Takeoka, Tomoaki Hoshino (2017). Nivolumab Maintenance as Monotherapy after Carboplatin Plus Nab- Paclitaxel for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Study Protocol for Feasibility. UNKNOWN, 7(5), 1-3. https://europub.co.uk./articles/-A-387005